Effects of erythropoietin-dextran microparticle-based PLGA/PLA microspheres on RGCS

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 10, 2012, Pages 6025-6034

  Mo, Xiaofen ^a   Rong, Xianfang ^a   Yang, Sixing ^b   Miao, Huamao ^a   Guo, Tingting ^a   Wang, Zhenyu ^a   Shi, Wanru ^a   Yuan, Weien ^b   Jin, Tuo ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN GEL; ERYTHROPOIETIN; ERYTHROPOIETIN DEXTRAN POLYGLACTIN POLYLACTIDE MICROPARTICLE; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROSPHERE; POLYGLACTIN; POLYLACTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG STABILITY; IMMUNOHISTOCHEMISTRY; NERVE FIBER GROWTH; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OPTIC NERVE INJURY; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE;

ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; DEXTRANS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; ERYTHROPOIETIN; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LACTIC ACID; MALE; MICROSPHERES; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RETINAL DEGENERATION; RETINAL GANGLION CELLS;

EID: 84866064086     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9898     Document Type: Article

References (41)

1. Chen H, Weber AJ. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci. 2001;42:966-974.
2. Zhang CW, Lu Q, You SW, et al. CNTF and BDNF have similar effects on retinal ganglion cell survival but differential effects on nitric oxide synthase expression soon after optic nerve injury. Invest Ophthalmol Vis Sci. 2005;46:1497-1503.
3. Cen LP, Luo JM, Zhang CW, et al. Chemotactic effect of ciliary neurotrophic factor on macrophages in retinal ganglion cell survival and axonal regeneration. Invest Ophthalmol Vis Sci. 2007;48:4257-4266.
4. Lingor P, Tonges L, Pieper N, et al. ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Brain. 2008;131(Pt 1):250-263.
5. Weishaupt JH, Rohde G, Polkking E, Siren AL, Ehrenreich H, Bahr M. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 2004;45: 1514-1522.
6. Junk AK, Mammis A, Savitz SI, et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA. 2002;99:10659-10664.
7. Wang Z, Shen L, Tu LL, et al. Erythropoietin protects retinal pigment epithelial cells from oxidative damage. Free Radic Biol Med. 2009;46:1032-1041.
8. Rex TS, Wong Y, Kodali K, Merry S. Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp Eye Res. 2009;89:735-740.
9. Zhong L, Bradley J, Schubert W, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci. 2007;48:1212-1218.
10. Hernandez C, Simó R. Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy. Endocrine. 2012;41:220-226.
11. Zhang J, Wu Y, Jin Y, et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci. 2008;49: 732-742.
12. Xie Z, Chen F, Wu X, et al. Safety and efficacy of intravitreal injection of recombinant erythropoietin for protection of photoreceptor cells in a rat model of retinal detachment. Eye (Lond.). 2012;26:144-152.
13. Gawad A, Schlichting L, Strauß O, Zeitz O. Antiapoptotic properties of erythropoietin: novel strategies for protection of retinal pigment epithelial cells. Eye (Lond). 2009;23:2245-2250.
14. King CE, Rodger J, Bartlett C, Esmaili T, Dunlop SA, Beazley LD. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol. 2007;205: 48-55.
15. Böcker-Meffert S, Rosenstiel P, Rohl C, et al. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest Ophthalmol Vis Sci. 2002;43:2021-2026.
16. Kretz A, Happold CJ, Marticke JK, Isenmann S. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci. 2005; 29:569-579.
17. Prasad AG, Schadlu R, Apte RS. Intravitreal pharmacotherapy: applications in retinal disease. Compr Ophthalmol Update. 2007;8:259-269.
18. Sinha V, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261-280.
19. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1-20.
20. Giordano GG, Chevez-Barrios P, Refojo MF, Garcia CA. Biodegradation and tissue reaction to intravitreous biodegradable poly (D, L-lactic-co-glycolic) acid microspheres. Curr Eye Res. 1995;14:761-768.
21. Veloso A, Zhu Q, Herrero-Vanrell R, Refojo ME Ganciclovirloaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. Invest Ophthalmol Vis Sci. 1997;38: 665-675.
22. Jin T, Zhu J, Wu F, Yuan W, Geng LL, Zhu H. Preparing polymerbased sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagents. J Control Release. 2008;128:50-59.
23. Morita T, Horikiri Y, Yamahara H, Suzuki T, Yoshino H. Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly (ethylene glycol) aqueous mixture. Pharm Res. 2000;17:1367-1373.
24. Johnson OFL, Jaworowicz W, Cleland JL, et al. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm Res. 1997;14:730-735.
25. Zale SE, Burke PA, Bernstein H, Brickner A, Inventors. Composition for sustained release of non-aggregated erythropoietin. US Patent US5716644. February 10, 1998.
26. Yuan W, Wu F, Geng Y, Xu S, Jin T Preparation of dextran glassy particles through freezing-induced phase separation. Int J Pharm. 2007;339:76-83.
27. Geng Y, Yuan W, Wu F, Chen J, He M, Jin T. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Control Release. 2008;130: 259-265.
28. Rong X, Mo X, Ren T, et al. Neuroprotective effect of erythropoietin-loaded composite microspheres on retinal ganglion cells in rats. Eur J Pharm Sci. 2011;43:334-342.
29. Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC. Intravitreal triamcinolone acetonide inhibits breakdown of the blood retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes. 2008;57: 1026-1033.
30. Dezawa M, Takano M, Negishi H, Mo X, Oshitari T, Sawada H. Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach. Micron. 2002;33:1-6.
31. Takano M, Horie H. Critical period for degradation of adult rat retinal ganglion cells and their regeneration capability after axotomy. Neurosci Lett. 1994;175:129-132.
32. Oshitari T, Dezawa M, Okada S, et al. The role of c-fos in cell death and regeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2002;43:2442.
33. Duplay D. Physicians' Desk Reference. Montvale, NJ: Thomson Healthcare Inc.; 2004.
34. Drüüeke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. New Engl J Med. 2006;355:2071-2084.
35. Bien A, Seidenbecher CI, Böckers TM, Sabel BA, Kreutz MR. Apoptotic versus necrotic characteristics of retinal ganglion cell death after partial optic nerve injury. J Neurotrauma. 1999;16:153-163.
36. Shen J, Wu Y, Xu JY, et al. ERK-and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest Ophthalmol Vis Sci. 2010;51:35-46.
37. Middeldorp J, Hol EM. GFAP in health and disease. Prog Neurobiol. 2011;93:421-443.
38. Wang X, Tay SS, Ng YK. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp Brain Res. 2000;132:476-484.
39. Chen H, Weber AJ. Expression of glial fibrillary acidic protein and glutamine synthetase by Müller cells after optic nerve damage and intravitreal application of brain-derived neurotrophic factor. Glia. 2002;38:115-125.
40. Woldemussie E, Wijono M, Ruiz G. Müller cell response to laser-induced increase in intraocular pressure in rats. Glia. 2004;47:109-119.
41. Hu LM, Luo Y, Zhang J, et al. EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells. Front Biosci (Elite Ed). 2011;3:1541-1555.